NCT06611033View on ClinicalTrials.gov

A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

December 16, 2025

Study Completion Date

December 16, 2025

Conditions
Healthy
Interventions
BIOLOGICAL

V118C

Intramuscular Administration

BIOLOGICAL

V118

Intramuscular Administration

BIOLOGICAL

PREVNAR 20™

Intramuscular Administration

BIOLOGICAL

Saline

Intramuscular Administration

Trial Locations (3)

33009

Velocity Clinical Research, Hallandale Beach ( Site 0003), Hallandale

33024

Research Centers of America ( Hollywood ) ( Site 0002), Hollywood

77555-1115

University of Texas Medical Branch ( Site 0001), Galveston

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY